Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-31 @ 10:42 PM
Study NCT ID:
NCT00132756
Status:
TERMINATED
Last Update Posted:
2006-11-08
First Post:
2005-08-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer
Sponsor:
Morton Plant Mease Health Care
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
DO03-25-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |